CBU
WGS icon

CIBC Bancorp USA’s GeneDx Holdings WGS Stock Holding History

CIBC Bancorp USA’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$216K Buy
+2,001
New +$218K ﹤0.01% 1223

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

CIBC Bancorp USA's WGS Position: Q3 2025 in Review

CIBC Bancorp USA opened a new position in GeneDx Holdings (WGS) in Q3 2025: 2,001 shares worth $216K. The stake represents ﹤0.01% of the portfolio and ranks #1223 among its holdings.

268 funds tracked by Wall St. Rank hold WGS as of Q3 2025.

  • CIBC Bancorp USA held 2,001 shares of GeneDx Holdings worth $216K as of Q3 2025.
  • GeneDx Holdings was a new CIBC Bancorp USA position in Q3 2025.
  • GeneDx Holdings made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2025, its #1223 holding.
  • 268 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2025.

Based on CIBC Bancorp USA's 13F filing for Q3 2025, filed 12 Nov 2025.